Sign up
Pharma Capital

PreveCeutical Medical's stock split to take place on May 24

Shareholders have previously agreed the move, which will be on the basis of five new shares for each one existing (5:1)..
price screen
The split will take place tomorrow (Thursday)
Health sciences and preventative medicines firm PreveCeutical Medical Inc (CSE:PREV, OTCQB:PRVCF) says its previously announced stock split will take place on May 24 this year.
 
Shareholders have previously agreed the move, which will be on the basis of five new shares for each one existing (5:1).
 
As of today (Wednesday), shares have begun trading on the Canadian Securities Exchange on an ex-distribution basis.
 
Preveceutical develops innovative options for preventive and curative therapies utilising organic and nature identical products.
 
"We believe the stock split demonstrates the company's continued commitment to broaden its shareholder base and we anticipate that the stock split will make PreveCeutical's securities more accessible to investors and enhance liquidity for shareholders,” president and chairman Stephen Van Deventer said earlier this month.
View full PREV profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.